Robert Taub serves as Executive at Omrix Biopharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Robert Taub has executed 6 insider transactions totaling $24.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 23, 2008 involved receiving (via award) 40,000 shares valued at $0.
Robert Taub currently holds 2,837,103 shares of Omrix Biopharmaceuticals, Inc. (OMRI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Taub has been a net seller of OMRI stock. They have purchased $979.3K and sold $23.6M worth of shares.
Robert Taub's most recent insider trade was on Nov 23, 2008, when they sold 40,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $12.10 |
| Discretionary |
| Mar 19, 2008 | OMRI | $659.8K | Purchase | 53,600 | $12.31 | Discretionary |
| Jan 17, 2007 | OMRI | $3.1M | Sale | 102,391 | $30.08 | Discretionary |
| Dec 20, 2006 | OMRI | $20.5M | Sale | 682,606 | $30.08 | Discretionary |
| Nov 30, 2006 | OMRI | $0 | Award | 36,364 | $N/A | Discretionary |